Teva Pharmaceutical Industries (TEVA) Acquisitions (2022 - 2024)

Teva Pharmaceutical Industries (TEVA) recorded quarterly Acquisitions of $15.0 million in Q1 2024, up 114.29% on a QoQ basis from $7.0 million in Q1 2022.

Teva Pharmaceutical Industries (TEVA) Acquisitions (2022 - 2024) Analysis & Trends

Teva Pharmaceutical Industries has disclosed Acquisitions across 2 years of filings, most recently posting $15.0 million for Q1 2024.

  • Quarterly Acquisitions changed N/A year-over-year to $15.0 million in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $15.0 million (changed N/A YoY) and the FY2024 annual result came in at $15.0 million, changed N/A from the prior year.
  • Acquisitions grew to $15.0 million in Q1 2024, from $7.0 million in the prior quarter.
  • Over five years, Acquisitions peaked at $15.0 million in Q1 2024 and troughed at $7.0 million in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.09 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 137.87 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 15.00 Mn
Mar 31, 2022 7.00 Mn